Internal Medicine · Johnson City, TN
NPI
1629073846
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
301 Med Tech Pkwy, Ste 240
Johnson City, TN, 37604
Phone (423) 794-5520
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
11,657 services
Medicare patients, 2024
419
Average age 76
Drug cost, 2024
$1.6M
15,289 prescriptions
Company payments, 2025
$549
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin D Sweet was code J0897 (injection, denosumab, 1 mg), 1,020 times for 12 patients. In total Kevin D Sweet billed 11,657 services in 132 codes, and Medicare paid $206K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,020 | 12 | $20.51 | $21K |
| 36415 Venipuncture Blood Collection | Office | 700 | 327 | $8.58 | $6,009 |
| 99214 Office E&M - Established | Office | 519 | 256 | $80.75 | $42K |
| 99213 Office E&M - Established | Office | 396 | 255 | $53.75 | $21K |
| 85025 Blood Count | Office | 359 | 272 | $7.51 | $2,696 |
| 80053 Clinical Chemistry | Office | 301 | 267 | $10.20 | $3,070 |
| 80061 Clinical Chemistry | Office | 284 | 256 | $13.12 | $3,726 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 266 | 266 | $119.02 | $32K |
| 83036 Blood Count | Office | 221 | 113 | $9.52 | $2,104 |
| 80048 Clinical Chemistry | Office | 177 | 103 | $8.29 | $1,467 |
| 81003 Clinical Chemistry | Office | 154 | 143 | $2.20 | $339 |
| 81001 Clinical Chemistry | Office | 153 | 131 | $3.11 | $476 |
| 85610 Clinical Chemistry | Office | 152 | 18 | $4.20 | $638 |
| 82570 Clinical Chemistry | Office | 152 | 149 | $5.08 | $772 |
| 82043 Clinical Chemistry | Office | 151 | 149 | $5.66 | $855 |
By year: 2022 $180K for 16,446 services; 2023 $197K for 15,210 services; 2024 $206K for 11,657 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 700 | 327 | $8.58 | $6,009 |
| 85025 Blood Count | 359 | 272 | $7.51 | $2,696 |
| 80053 Clinical Chemistry | 301 | 267 | $10.20 | $3,070 |
| 80061 Clinical Chemistry | 284 | 256 | $13.12 | $3,726 |
| 83036 Blood Count | 221 | 113 | $9.52 | $2,104 |
| 80048 Clinical Chemistry | 177 | 103 | $8.29 | $1,467 |
| 81003 Clinical Chemistry | 154 | 143 | $2.20 | $339 |
| 81001 Clinical Chemistry | 153 | 131 | $3.11 | $476 |
| 85610 Clinical Chemistry | 152 | 18 | $4.20 | $638 |
| 82570 Clinical Chemistry | 152 | 149 | $5.08 | $772 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin D Sweet prescribed most often to Medicare patients was Atorvastatin Calcium, with 685 prescriptions and refills. In total Kevin D Sweet wrote 15,289 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 685 | 1,833 | 172 | $6,720 |
| Rosuvastatin Calcium Generic | 574 | 1,656 | 161 | $5,461 |
| Levothyroxine Sodium Generic | 515 | 1,310 | 122 | $4,373 |
| Omeprazole Generic | 478 | 1,290 | 130 | $8,256 |
| Amlodipine Besylate Generic | 444 | 1,258 | 131 | $2,644 |
| Lisinopril Generic | 398 | 1,116 | 102 | $2,475 |
| Gabapentin Generic | 342 | 520 | 68 | $4,508 |
| Losartan Potassium Generic | 337 | 939 | 89 | $3,241 |
| Potassium Chloride Generic | 332 | 808 | 95 | $7,569 |
| Furosemide Generic | 302 | 707 | 94 | $1,273 |
| Tamsulosin Hcl Generic | 273 | 739 | 72 | $3,172 |
| Eliquis Apixaban | 272 | 446 | 51 | $258K |
| Metoprolol Succinate Generic | 227 | 622 | 66 | $3,311 |
| Meloxicam Generic | 219 | 475 | 51 | $870 |
| Metformin Hcl Er Metformin Hcl | 217 | 596 | 68 | $1,469 |
Brand drugs: 2,145 claims; generic drugs: 12,968 claims; opioid claims: 431.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin D Sweet $549 ($549 in general payments such as food, travel and fees) from 10 companies. The largest payer was Lilly USA, LLC with $136.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 8 | $136 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $109 |
| GlaxoSmithKline, LLC. GSK | 5 | $81.49 |
| Abbvie Inc. ABBV | 2 | $52.43 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $47.19 |
| Novo Nordisk Inc NVO | 2 | $37.18 |
| Pfizer Inc. PFE | 2 | $28.66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $22.67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20.82 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $13.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.